Increased Engraftment of Hepatic Progenitors After Activation of the Hepatocyte Growth Factor Signaling Pathway by Protein Transduction

被引:8
作者
Kellermann, Guillaume [1 ]
Boudechiche, Lyes
Weber, Anne
Hadchouel, Michelle
机构
[1] INSERM, U804, F-94276 Le Kremlin Bicetre, France
关键词
HGF; TAT; protein transduction; hepatocyte transplantation; RECEPTOR TYROSINE KINASE; FACTOR SCATTER FACTOR; TAT-FUSION PROTEINS; TPR-MET; CELL TRANSPLANTATION; MAMMALIAN-CELLS; RAT-LIVER; DELIVERY; METASTASIS; PEPTIDES;
D O I
10.3181/0901-RM-32
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Cell transplantation has become a major focus in biomedical research. However, efficient engraftment in solid tissues remains a challenge. Hepatocyte growth factor (HGF) signaling increases survival, proliferation, migration, and invasion of many cell types through Met, its cell surface receptor. Therefore, activation of this signaling pathway may improve the ability of many cells to be transplanted. We constructed a constitutively activated form of Met (Tpr-Met) fused to the protein transduction domain of HIV-TAT to activate the HGF/Met pathway for a few hours following cell injection. Matrix-assisted refolding was used to renature TAT-Tpr-Met protein, which was efficiently delivered into cells and recapitulated several biological functions of Met in vitro. Furthermore, treatment of hepatic progenitors with this molecule for one hour before transplantation significantly improved engraftment efficiency (31% untreated cells, 58% treated cells). These findings suggest that the transient transfer of Tpr-Met may provide a new approach to increase the proportion of successfully engrafted cells. Exp Biol Med 234:1102-1108, 2009
引用
收藏
页码:1102 / 1108
页数:7
相关论文
共 30 条
[1]   Liver cell transplantation: The road to clinical application [J].
Allen, KJ ;
Soriano, HE .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2001, 138 (05) :298-312
[2]   TAT-mediated protein transduction into mammalian cells [J].
Becker-Hapak, M ;
McAllister, SS ;
Dowdy, SF .
METHODS, 2001, 24 (03) :247-256
[3]  
BELLUSCI S, 1994, ONCOGENE, V9, P1091
[4]   Met, metastasis, motility and more [J].
Birchmeier, C ;
Birchmeier, W ;
Gherardi, E ;
Vande Woude, GF .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (12) :915-925
[5]   A differentiation switch for genetically modified hepatocytes [J].
Boccaccio, C ;
Andò, M ;
Comoglio, PM .
FASEB JOURNAL, 2001, 15 (13) :120-+
[6]   CHARACTERIZATION OF THE REARRANGED TPR-MET ONCOGENE BREAKPOINT [J].
DEAN, M ;
PARK, M ;
VANDEWOUDE, GF .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (02) :921-924
[7]   Delivery of bioactive molecules into the cell:: The Trojan horse approach [J].
Dietz, GPH ;
Bähr, M .
MOLECULAR AND CELLULAR NEUROSCIENCE, 2004, 27 (02) :85-131
[8]   Improving islet transplantation by gene delivery of hepatocyte growth factor (HGF) and its downstream target, protein kinase B (PKB)/Akt [J].
Fiaschi-Taesch, Nathalie ;
Stewart, Andrew F. ;
Garcia-Ocana, Adolfo .
CELL BIOCHEMISTRY AND BIOPHYSICS, 2007, 48 (2-3) :191-199
[9]   Arginine-rich peptides - An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery [J].
Futaki, S ;
Suzuki, T ;
Ohashi, W ;
Yagami, T ;
Tanaka, S ;
Ueda, K ;
Sugiura, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (08) :5836-5840
[10]   Transgenic overexpression of hepatocyte growth factor in the β-cell markedly improves islet function and islet transplant outcomes in mice [J].
García-Ocaña, A ;
Vasavada, RC ;
Cebrian, A ;
Reddy, V ;
Takane, KK ;
López-Talavera, JC ;
Stewart, AF .
DIABETES, 2001, 50 (12) :2752-2762